LifeVantage (LFVN) Projected to Post Earnings on Tuesday

LifeVantage (NASDAQ:LFVNGet Free Report) is expected to be announcing its earnings results before the market opens on Tuesday, January 28th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $51,900.00 billion for the quarter. LifeVantage has set its FY 2025 guidance at 0.700-0.800 EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

LifeVantage (NASDAQ:LFVNGet Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%. The firm had revenue of $47.21 million for the quarter.

LifeVantage Trading Up 1.1 %

Shares of NASDAQ LFVN opened at $24.24 on Friday. The company has a market capitalization of $303.48 million, a P/E ratio of 75.75 and a beta of 0.82. LifeVantage has a 12 month low of $5.22 and a 12 month high of $27.38. The stock has a 50 day moving average of $17.80 and a 200-day moving average of $12.77.

Wall Street Analysts Forecast Growth

LFVN has been the subject of a number of research analyst reports. Craig Hallum began coverage on shares of LifeVantage in a research report on Tuesday, January 14th. They set a “buy” rating and a $35.00 price objective for the company. Lake Street Capital assumed coverage on shares of LifeVantage in a report on Thursday, December 19th. They set a “buy” rating and a $26.00 target price for the company.

Check Out Our Latest Analysis on LFVN

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Further Reading

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.